Factsheets & Guidelines

Below are some answers to frequently asked questions about Mifegymiso and medical abortion as well as a link to our Mifegymiso pocket guide. 

• July 2015: Health Canada approves the abortion pill Mifegymiso, the Canadian brand name for the combination of Mifepristone and Misoprostol.
• January 2017: Mifegymiso roll-out begin

Canada received global praise in 2017 with a bold $650 million three-year investment in women’s sexual and reproductive health and rights (SRHR).

Planned and regulated task shifting and task sharing can have a range of benefits.